Contact
Please use this form to send email to PR contact of this press release:
Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-A Plus CLAG-M
TO:
Please use this form to send email to PR contact of this press release:
Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-A Plus CLAG-M
TO: